NELLI MURTAZINA: Open Payments
NPI 1720690399 · MONUMENT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 27 payments from 15 companies in 2025. Trend: 2023 $523 · 2024 $313 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Alkermes, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $42 |
| Braeburn Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Bausch Health US, LLC | 2 | $37 |
| Indivior Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
Products named: INGREZZA, Auvelity, REXULTI, ARISTADA, VRAYLAR, BRIXADI, AUSTEDO XR, APLENZIN.
Industry payments across CO — which companies pay providers there.
